solid tumour harbouring G12C mutation research hub

A study to test different doses of BI 1823911 alone and combined with other medicines in people with different types of advanced cancer with KRAS mutation.

This study is for people with advanced cancers that have a specific genetic change called a KRAS G12C mutation. It's testing new medicines, including one called BI 1823911, to see how different doses work and if they're better when combined with other treatments.